Fierce Biotech

  • Biopharmas recorded 62 layoff rounds, just a smidge lower than the 64 reported both in the first and second quarter each, according to Fierce Biotech’s Layoff Tracker.

  • Jeanne Marrazzo, M.D., the former director of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID), was fired from her position three weeks after filing a whistleblower complaint, according to an Oct. 1 statement from Marrazzo’s legal team.

  • Biopharma is set to lose two of the industry’s rare women CEOs—GSK’s Emma Walmsley and Merck KGaA's Belén Garijo—leaving a dearth of women-helmed large life sciences companies.

  • Having already altered the journey of its rare disease gene therapy to a hoped-for FDA approval, Rocket Pharmaceuticals has now aborted the mission entirely.

  • The first woman to helm a Big Pharma will be stepping down in January as GSK’s Emma Walmsley moves aside for her chief commercial officer Luke Miels. Walmsley, 56, who became the British pharma’s CEO back in 2017, will officially leave Jan. 1, 2026.

Main Menu